2022 Revenues ($USD) : $788,000,000
2022 R&D spend : n/a
2022 Number of Employees : 3,500
Fiscal Year End : 12/31/2021
Company CEO : Shar Matin, CEO

Miami Lakes, Florida–based Cordis joins the Big 100 rankings of largest medical device companies after Cardinal Health’s sale of the business. Cardinal Health sold Cordis to private equity firm Hellman & Friedman in 2021 for $1 billion. The deal came six years after Cardinal Health bought Cordis and its minimally-invasive cardiovascular technology from J&J for nearly $2 billion. Cordis develops cardiovascular and endovascular products and services. The company’s reach spans more than 70 countries around the world, with global headquarters in Baar, Switzerland. The company focuses on vascular closure, radial, pedal access, and intervention, among other cardiovascular challenges. –SW